SECURE Webinar 12: Strengthening Health Surveillance and Diagnostic Capacity in Indonesia Read more about SECURE Webinar 12: Strengthening Health Surveillance and Diagnostic Capacity in Indonesia
Do Tuan Dat Keywords Health SECURE COVID-19 health communication Green Initiatives to Health Facilities Read more about Do Tuan Dat Do Tuan Dat is a vaccine scientific, production, and business adviser in the Company for Vaccine and Biological Production (VABIOTECH) where he is responsible as a Senior Consultant. In this position, he consults all the R&D, quality management, production, and business activities in VABIOTECH. Before working at VABIOTECH, he studied at the Clinical Institute of Tropical and Infectious Diseases, Vietnam where he conducted research in the field of tropical and infectious diseases.
SECURE Webinar 11: Strengthening Domestic Vaccine Development and Manufacturing in Viet Nam Read more about SECURE Webinar 11: Strengthening Domestic Vaccine Development and Manufacturing in Viet Nam The COVID-19 pandemic served as a wake-up call for many upper-middle-income country (UMIC) and low-and-middle-income country (LMIC) governments.
Closing the Diagnostic Gap: RIGHT Foundation’s Approach Read more about Closing the Diagnostic Gap: RIGHT Foundation’s Approach This presentation gives an overview of RIGHT Foundation aspiration to contribute to closing the diagnostic gap.
Diagnostics Procurement Bottlenecks: A Diagnosis and Some Curative Suggestions Read more about Diagnostics Procurement Bottlenecks: A Diagnosis and Some Curative Suggestions This presentation gives an overview of ADB's diagnostics procurement bottlenecks and some curative suggestions.
Increasing Access on TB Diagnostics: Supplementing Laboratory Capacity at the Local Level and Scaling Up Active Case Finding Read more about Increasing Access on TB Diagnostics: Supplementing Laboratory Capacity at the Local Level and Scaling Up Active Case Finding This presentation gives an overview on supplementing laboratory capacity at the local level and scaling up active case finding.
Svilen Konov Keywords green economy Health SECURE COVID-19 health communication Green Initiatives to Health Facilities Read more about Svilen Konov Svilen Konov has a degree from the London School of Hygiene and Tropical Medicine. He has worked as a clinical trials methodologist on drug development, predominantly in the field of HIV and HCV as well as concomitant diseases, with large pharmaceutical companies and has developed research protocols and analysis plans. He has experience working with the EU regulator, the European Medicines Agency (EMA) on drug approval. In addition. Svilen worked with the World Health Organization on Emergency Medical Services (EMS).
Hani Kim Keywords green economy Health SECURE COVID-19 health communication Green Initiatives to Health Facilities Read more about Hani Kim Hani Kim is the Executive Director of the RIGHT (Research Investment in Global Health Technology) Foundation. She completed her PhD in Lab Medicine and Pathobiology at the University of Toronto, Canada, her post-doctoral training in molecular immunology at the Max-Planck Institute of Immunology, Germany, and her MPH at the Johns Hopkins School of Public Health, U.S.A. Before joining the RIGHT Foundation, Hani worked as a Program Officer at the Bill & Melinda Gates Foundation, and as a Research Associate at the Johns Hopkins School of Public Health.
Mary Ruth Roxas Keywords green economy Health SECURE COVID-19 health communication Green Initiatives to Health Facilities Read more about Mary Ruth Roxas Dr.
SECURE Webinar 10: Pandemic Preparedness and Response: Increasing Access to Diagnostics Today Read more about SECURE Webinar 10: Pandemic Preparedness and Response: Increasing Access to Diagnostics Today The COVID-19 pandemic demonstrated the gap of diagnostics capacities between countries, and how diagnostic capacities directly lead to response capacity. The pandemic was also a time for countries to review existing resources, technologies, and capabilities to diagnose, and for the world to realize the importance of diagnostics for disease response.